Emory University School of Medicine
Dr. Lily Yang holds multiple NIH grants and is a translational cancer researcher who specializes in the development of novel cancer imaging and targeted therapeutic agents. she is the Professor of Surgery and Nancy Panoz Chair of Surgery in Cancer Research, Department of Surgery, Emory University School of Medicine. Her research experiences include tumor immunology, cancer stem cells, cancer gene therapy, apoptosis resistance, molecular targeted cancer therapy, nanoparticle imaging probes, and theranostic nanoparticles for targeted cancer therapy and imaging. Dr. Yang is a member of the Cancer Cell Biology Research Program at Winship Cancer Institute of Emory University, and holds professional memberships with American Association for Cancer Research, American Society of Nanomedicine, and National Cancer Institute Alliance for Nanotechnology in Cancer. Her research projects focus on the development of novel cancer nanotechnologies and imaging methods to address the major challenges in clinical oncology of early cancer detection, targeted drug delivery, overcoming drug resistance, assessment of therapeutic response using non-invasive imaging, and image-guided surgery
Tumor immunology, Cancer stem cells and Molecular targeted cancer therapy.